Matches in Nanopublications for { ?s ?p "[LUX-Lung 3 was a pivotal randomized Phase III study that recently led to the approval of afatinib (Gilotrif) in several countries for treatment of patients with metastatic NSCLC harboring somatic EGFR gene mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- NP1175646.RAiyoKOkXTe3XAFXThbWsFjeyZhEG2Y_CGodDeFr0uu34130_assertion description "[LUX-Lung 3 was a pivotal randomized Phase III study that recently led to the approval of afatinib (Gilotrif) in several countries for treatment of patients with metastatic NSCLC harboring somatic EGFR gene mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1175646.RAiyoKOkXTe3XAFXThbWsFjeyZhEG2Y_CGodDeFr0uu34130_provenance.